Generic Drugs
Lower cost generic drugs for lower income consumers
Published in Mental Health Business Week, April 8th, 2006
The broader coverage will increase the number of generic drugs offered to 107, and became effective March 1. The program offers drugs in 19 of the top 25 therapeutic classes. Rx Outreach saved 267,000 patients more than $61 million while filling 771,000 prescriptions in 2005. Millions of uninsured and underinsured Americans are eligible for the program.
Medications available through Rx Outreach help treat ongoing health problems like diabetes, asthma, high blood...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Mental Health Business Week
More Articles from Mental Health Business Week
- Cortex Pharmaceuticals, Inc.
Adult ADHD study with CX717 shows positive results, reports Cortex - John Wiley & Sons, Inc.
Disclosing study outcomes to participants may backfire - Neurogen Corporation
Neurogen Corporation announces $10.6 million net loss for the fourth quarter of 2005 - Neuromed Pharmaceuticals Ltd.
Neuromed raises US$25 million, completing fourth-round private equity financing - Nordic Naturals, Inc.
Nutritional and program interventions improve functional behaviors among Mexican orphans - StemCells, Inc.
Oregon IRB approves phase 1 trial using purified human neural stem cells in Batten disease - More from this issue of Mental Health Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
